Nobuhiro Hashimoto

1.2k total citations
45 papers, 801 citations indexed

About

Nobuhiro Hashimoto is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nobuhiro Hashimoto has authored 45 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 11 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nobuhiro Hashimoto's work include Parathyroid Disorders and Treatments (7 papers), Dialysis and Renal Disease Management (6 papers) and Potassium and Related Disorders (5 papers). Nobuhiro Hashimoto is often cited by papers focused on Parathyroid Disorders and Treatments (7 papers), Dialysis and Renal Disease Management (6 papers) and Potassium and Related Disorders (5 papers). Nobuhiro Hashimoto collaborates with scholars based in Japan, United States and Ukraine. Nobuhiro Hashimoto's co-authors include Kenji Kurihara, Yoshitaka Isaka, Yusuke Sakaguchi, Isao Matsui, Tatsufumi Oka, Takayuki Hamano, Ayumi Matsumoto, Karin Shimada, Satoshi Yamaguchi and Keiichi Kubota and has published in prestigious journals such as Circulation, PLoS ONE and Stroke.

In The Last Decade

Nobuhiro Hashimoto

40 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuhiro Hashimoto Japan 17 328 174 156 152 149 45 801
Mathias Haarhaus Sweden 20 672 2.0× 130 0.7× 233 1.5× 101 0.7× 217 1.5× 54 1.2k
Jau-Yi Li United States 8 252 0.8× 119 0.7× 613 3.9× 104 0.7× 168 1.1× 8 1.3k
T. Malachi Israel 15 169 0.5× 44 0.3× 203 1.3× 109 0.7× 165 1.1× 33 739
Sait Şen Türkiye 18 375 1.1× 45 0.3× 256 1.6× 179 1.2× 95 0.6× 92 968
Zhi Zhao China 17 231 0.7× 52 0.3× 418 2.7× 235 1.5× 87 0.6× 40 912
Márcio Dantas Brazil 16 270 0.8× 29 0.2× 151 1.0× 88 0.6× 52 0.3× 63 742
Danuta Fedak Poland 15 106 0.3× 56 0.3× 140 0.9× 61 0.4× 56 0.4× 43 615
Anja Urbschat Germany 17 223 0.7× 29 0.2× 202 1.3× 127 0.8× 71 0.5× 34 808
Faysal Gök Türkiye 18 189 0.6× 33 0.2× 289 1.9× 255 1.7× 49 0.3× 70 934
David Sherman United Kingdom 15 130 0.4× 85 0.5× 150 1.0× 62 0.4× 112 0.8× 34 835

Countries citing papers authored by Nobuhiro Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Nobuhiro Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Hashimoto more than expected).

Fields of papers citing papers by Nobuhiro Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Hashimoto. The network helps show where Nobuhiro Hashimoto may publish in the future.

Co-authorship network of co-authors of Nobuhiro Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Hashimoto. A scholar is included among the top collaborators of Nobuhiro Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Hashimoto. Nobuhiro Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doi, Yohei, Maki Shinzawa, Hideaki Oka, et al.. (2025). Empagliflozin and Ultrafiltration Volume in Patients Undergoing Peritoneal Dialysis. Kidney International Reports. 11(1). 141–151. 1 indexed citations
2.
Hashimoto, Nobuhiro, Yusuke Sakaguchi, Yuki Kawano, et al.. (2025). Discontinuing renin-angiotensin system inhibitors after incident hyperkalemia and clinical outcomes: target trial emulation. Hypertension Research. 48(7). 2034–2044.
3.
Sakaguchi, Yusuke, Tatsufumi Oka, Yohei Doi, et al.. (2024). Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality. Journal of the American Society of Nephrology. 35(10). 1391–1401. 5 indexed citations
4.
Hashimoto, Nobuhiro, et al.. (2023). Fatal peritoneal dialysis-associated peritonitis caused by Mycobacterium mageritense: a case report with review. Renal Replacement Therapy. 9(1). 1 indexed citations
5.
6.
Hashimoto, Nobuhiro, et al.. (2023). Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist. Journal of Nephrology. 36(5). 1439–1442. 4 indexed citations
7.
8.
Oka, Tatsufumi, Takayuki Hamano, Tomohito Ohtani, et al.. (2021). Renoprotection by Long-Term Low-Dose Tolvaptan in Patients with Heart Failure and Hyponatremia. ESC Heart Failure. 8(6). 4904–4914. 4 indexed citations
9.
Yamaguchi, Satoshi, Takayuki Hamano, Yohei Doi, et al.. (2020). Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis. Scientific Reports. 10(1). 4418–4418. 27 indexed citations
10.
Hashimoto, Nobuhiro, Isao Matsui, Satoshi Ishizuka, et al.. (2020). Lithocholic acid increases intestinal phosphate and calcium absorption in a vitamin D receptor dependent but transcellular pathway independent manner. Kidney International. 97(6). 1164–1180. 35 indexed citations
11.
Hashimoto, Nobuhiro, Sumito Dateki, Takatoshi Tsuchihashi, et al.. (2020). Compound heterozygous variants in the ABCG8 gene in a Japanese girl with sitosterolemia. Human Genome Variation. 7(1). 25–25. 2 indexed citations
12.
Mori, Daisuke, Isao Matsui, Akihiro Shimomura, et al.. (2018). Protein carbamylation exacerbates vascular calcification. Kidney International. 94(1). 72–90. 45 indexed citations
13.
Matsumoto, Ayumi, Isao Matsui, Tomoko Namba‐Hamano, et al.. (2018). VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases. American Journal of Kidney Diseases. 73(6). 880–885. 20 indexed citations
14.
Hayashi, Terumasa, Keiko Yasuda, Tomonori Kimura, et al.. (2018). Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease. American Journal of Nephrology. 48(3). 205–213. 7 indexed citations
15.
Kubota, Keiichi, Yusuke Sakaguchi, Takayuki Hamano, et al.. (2018). Prognostic value of hypochloremia versus hyponatremia among patients with chronic kidney disease—a retrospective cohort study. Nephrology Dialysis Transplantation. 35(6). 987–994. 27 indexed citations
16.
Sakaguchi, Yusuke, Takayuki Hamano, Chikako Nakano, et al.. (2016). Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease. PLoS ONE. 11(9). e0163673–e0163673. 33 indexed citations
17.
Yokohira, Masanao, Kazuhiro Yamakawa, Kousuke Saoo, et al.. (2008). Antioxidant Effects of Flavonoids Used as Food Additives (Purple Corn Color, Enzymatically Modified Isoquercitrin, and Isoquercitrin) on Liver Carcinogenesis in a Rat Medium‐Term Bioassay. Journal of Food Science. 73(7). C561–8. 36 indexed citations
18.
Mikami, Takeshi, et al.. (2004). 血しょうアジポネクチンは留置ステント再狭窄(ISR)の予測因子である. Circulation. 68. 263. 10 indexed citations
19.
Hashimoto, Nobuhiro, et al.. (1987). Pathological characteristics metastatic carcinoma in the human mandible. Journal of Oral Pathology and Medicine. 16(7). 362–367. 61 indexed citations
20.
Hashimoto, Nobuhiro, et al.. (1969). Histological investigation on the process of the fusion of the human mandibular symphysis. Japanese Journal of Oral Biology. 11(2). 49–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathias Haarhaus Breakdown of academic impact, for papers by Jau-Yi Li Breakdown of academic impact, for papers by T. Malachi Breakdown of academic impact, for papers by Sait Şen Breakdown of academic impact, for papers by Zhi Zhao Breakdown of academic impact, for papers by Márcio Dantas Breakdown of academic impact, for papers by Danuta Fedak Breakdown of academic impact, for papers by Anja Urbschat Breakdown of academic impact, for papers by Faysal Gök Breakdown of academic impact, for papers by David Sherman
Rankless by CCL
2026